BBIO BBIO R2K
$66.26
+93.46% 1Y
Market & Price
Market Cap
-
Current Price
$66.26
High / Low (52W)
$79.91 / $34.25
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-85.53%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.84
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$936.02M
Current Assets
$797.75M
Working Capital
$509.78M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
86.30%
Profit 5Y
-16.89%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Compounding revenue at 86.3% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -16.9% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 26.74M | - | - | 8.13M | 462.00K | 54.02M | 2.34M | 1.69M | 73.75M | 338.00K | 1.83M | 1.64M | 4.09M | 211.12M | 2.17M | - | - | 116.63M | 110.56M | 120.70M | 154.18M | 194.51M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.64M | 3.65M | 6.56M | 8.11M | 9.94M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 113.99M | 106.91M | 114.14M | 146.07M | 184.58M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 217.80M | 240.38M | 250.50M | 274.50M | 290.53M |
| Operating Income | -41.46M | -63.75M | -69.32M | -54.53M | -102.49M | -124.57M | -119.94M | -167.50M | -94.02M | -149.50M | -173.68M | -80.18M | -129.12M | -126.16M | -146.10M | -157.69M | 343.00K | -175.54M | - | - | -103.80M | -133.47M | -136.36M | -128.43M | -105.96M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -126.18M | -142.70M | -136.94M | -143.01M | -112.55M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.14M | 37.64M | 48.15M | 50.31M | 52.81M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -169.61M | -181.66M | -186.48M | -194.75M | -166.56M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.10M | -1.54M | -120.00K | - |
| Net Income | -31.40M | -61.19M | -65.96M | -59.98M | -91.85M | -121.03M | -115.86M | -163.08M | -96.35M | -155.94M | -196.40M | -9.86M | -137.34M | -140.16M | -157.90M | -177.00M | -35.22M | -73.46M | - | - | -167.42M | -181.90M | -182.74M | -192.86M | -164.04M |
| Diluted EPS | - | - | - | - | - | - | - | - | -0.66 | -1.06 | -1.35 | -0.07 | -0.93 | -0.92 | -0.98 | -1.08 | -0.20 | -0.39 | - | - | -0.88 | -0.95 | -0.95 | -1.00 | -0.84 |
| R&D Expense | 31.15M | 44.85M | 52.33M | 55.28M | 68.22M | 86.60M | 92.05M | 122.56M | 101.96M | 104.31M | 107.65M | 108.40M | 92.51M | 92.86M | 107.49M | 125.14M | 140.97M | 114.69M | 120.44M | - | 111.43M | 111.23M | 112.87M | - | 126.64M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 40.56M | 8.25M | - | 77.65M | 9.30M | 221.90M | 502.08M |
| Cost of Revenue | - | - | - | - | - | 3.43M | 2.45M | 3.88M | 20.96M |
| Gross Profit | - | - | - | - | - | 74.21M | 6.86M | 218.02M | 481.11M |
| Operating Expenses | - | - | - | - | - | 542.65M | 606.30M | 795.39M | 983.18M |
| Operating Income | -43.86M | -183.66M | -266.24M | -474.48M | - | -468.44M | -599.44M | -577.37M | -502.06M |
| EBITDA | - | - | - | - | - | -397.44M | -565.47M | -436.83M | -548.83M |
| Interest Expense | - | - | - | - | - | 80.44M | 81.29M | 99.29M | 178.24M |
| Pretax Income | - | - | - | - | - | -484.65M | -653.25M | -542.19M | -732.50M |
| Tax Provision | - | - | - | - | - | 0 | 0 | 1.15M | 435.00K |
| Net Income | -30.57M | -130.75M | -260.59M | -448.72M | - | -481.18M | -643.20M | -535.76M | -724.93M |
| Diluted EPS | - | - | - | -3.80 | - | -3.26 | -3.95 | -2.88 | -3.78 |
| R&D Expense | 30.56M | 140.07M | 209.95M | 337.05M | 451.02M | 399.46M | 455.71M | 506.46M | 451.95M |
Compounded Sales Growth
| 5 Years: | 86.30% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -16.89% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +93.46% |
| 6 Months: | -6.19% |
| 3 Months: | -0.33% |
| 1 Month: | -6.60% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 464.94M | 631.68M | 703.59M | - | 623.04M | 546.38M | 919.34M | 936.02M |
| Current Assets | - | - | - | - | - | - | 548.85M | 477.59M | 720.69M | 797.75M |
| Cash & Equivalents | - | 92.00M | 436.09M | 363.77M | 356.08M | - | 376.69M | 375.94M | 681.10M | 570.12M |
| Inventory | - | - | - | - | - | - | - | - | 0 | 26.75M |
| Receivables | - | - | - | - | - | - | - | 1.75M | 4.72M | 139.44M |
| Total Liabilities | - | - | 87.58M | 155.70M | 595.70M | - | 1.87B | 1.89B | 2.38B | 3.01B |
| Current Liabilities | - | - | 32.58M | 60.38M | 95.65M | - | 121.43M | 143.84M | 154.40M | 287.97M |
| Long Term Debt | - | - | 54.51M | 91.79M | 92.42M | - | 1.71B | 1.73B | 1.72B | 1.85B |
| Total Debt | - | - | - | - | - | - | 1.72B | 1.74B | 1.73B | 1.86B |
| Total Equity | 14.89M | 85.85M | 314.88M | 408.45M | 57.91M | - | -1.25B | -1.35B | -1.47B | -2.09B |
| Shares Outstanding | - | - | - | - | - | - | 156.82M | 181.27M | 196.24M | 202.37M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -40.49M | -136.64M | -253.59M | -399.71M | - | -419.49M | -527.72M | -520.73M | -445.91M |
| Investing Cash Flow | -464.00K | -21.04M | -217.25M | -52.99M | - | 453.15M | 54.03M | 60.78M | -24.49M |
| Financing Cash Flow | 112.98M | 501.55M | 398.79M | 447.19M | - | -13.13M | 451.54M | 748.46M | 359.29M |
| Capital Expenditure | -464.00K | -2.18M | -2.64M | -7.52M | - | -6.32M | -1.31M | -8.91M | -9.59M |
| Free Cash Flow | -40.95M | -138.82M | -256.23M | -407.23M | - | -425.81M | -529.03M | -529.63M | -455.50M |
| Net Change in Cash | - | - | - | - | - | 20.52M | -22.15M | 288.51M | -111.10M |
| Share Buybacks | - | - | - | 75.00M | 200.00M | 0 | 0 | 0 | 48.28M |
| Dividends Paid | 1.15M | - | 997.00K | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | 95.6% | 73.7% | 98.3% | 95.8% |
| Operating Margin % | - | - | -656.4% | -5,752.0% | - | -603.3% | -6,443.6% | -260.2% | -100.0% |
| Net Margin % | - | - | -642.5% | -5,439.7% | - | -619.7% | -6,913.9% | -241.4% | -144.4% |
| ROE % | -35.6% | -41.5% | -63.8% | -774.9% | - | 38.4% | 47.5% | 36.5% | 34.7% |
| ROCE % | - | -42.5% | -46.6% | -78.0% | - | -93.4% | -148.9% | -75.5% | -77.5% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BBIO
No recent headlines available.